Lisinopril
- Product NDC
- 42708-165
- 11-digit product format
- 427080165
- Labeler code
- 42708
- Product ID
- 42708-165_4681a929-3969-1024-e063-6394a90a0935
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Lisinopril
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- QPharma, Inc.
- Application
- ANDA077321
- Marketing category
- ANDA
- Marketing start
- 2017-05-12
- Substance
- LISINOPRIL
- Active strength
- 20 mg/1
- Pharmacologic classes
- Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Lisinopril
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| LISINOPRIL | 20 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | E7199S1YWR |
| Rxcui | 314077 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 42708-165-30 | Lisinopril | 30 in 1 BOTTLE, PLASTIC | TABLET | 30 | | 4 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 42708-165 | LISINOPRIL TABLET [QPHARMA INC] | 3 | Current NDC, 1 package rows | 20240515_f6f68322-f8a1-9011-e053-6394a90a1d2c.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 42708-165-30 | 42708016530 | 30 TABLET in 1 BOTTLE, PLASTIC (42708-165-30) | 30 tablet | 2023-03-15 | Yes | No | Historical |